{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:17:10Z","timestamp":1787167030852,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DEQ20180339216"],"award-info":[{"award-number":["DEQ20180339216"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["EQU202303016296"],"award-info":[{"award-number":["EQU202303016296"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DEQ20180339216"],"award-info":[{"award-number":["DEQ20180339216"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["EQU202303016296"],"award-info":[{"award-number":["EQU202303016296"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["Comit\u00e9s du Grand Ouest"],"award-info":[{"award-number":["Comit\u00e9s du Grand Ouest"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007525","name":"Universit\u00e9 de Rennes 1","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007525","id-type":"DOI","asserted-by":"publisher"}]},{"name":"INSERM; EHESP; Contrat de Plan Etat-R\u00e9gion (CPER) Grant \"Infectio\"."},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004562","name":"Minist\u00e8re de l'Education Nationale, de l'Enseignement Superieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The rising prevalence of hepatocellular carcinoma (HCC) in the last decade is mostly attributable to the growing epidemic of metabolic dysfunction-associated steatotic liver diseases (MASLD). However, the transition from steatosis to steatohepatitis (MASH) and ultimately to HCC is not fully understood. As an executioner protein of necroptosis, the mixed-lineage kinase domain-like protein (MLKL) has been proposed to contribute to MASH and HCC development. To investigate its role in disease progression, mice whose liver parenchymal cells (LPCs) no longer expressed MLKL (\n                    <jats:italic>Mlkl<\/jats:italic>\n                    <jats:sup>LPC-KO<\/jats:sup>\n                    ) were compared to their control counterparts (\n                    <jats:italic>Mlkl<\/jats:italic>\n                    <jats:sup>fl\/fl<\/jats:sup>\n                    ) using an experimental model combining diabetes induction and a high-fat high-sugar diet (HFHSD) for 4, 8, or 12 weeks. Notably, HFHSD failed to induce detectable hepatic necroptosis in\n                    <jats:italic>Mlkl<\/jats:italic>\n                    <jats:sup>fl\/fl<\/jats:sup>\n                    mice, with no phosphorylated MLKL observed by Western blot. Both genotypes displayed similar steatosis and mild fibrosis, consistent with comparable MASH severity, and this condition progressed to HCC. Interestingly, the incidence of liver tumors in\n                    <jats:italic>Mlkl<\/jats:italic>\n                    <jats:sup>LPC-KO<\/jats:sup>\n                    mice was significantly reduced, which was associated with a delay in the onset of systemic and hepatic inflammation. At the early stage of the disease (4th week), the absence of MLKL in LPCs appeared to confer a protective effect on the liver, reducing metabolic stress, as reflected by a lower ceramide-to- sphingomyelin ratio, along with oxidative stress and DNA damage. Altogether, our data suggest that MLKL in LPCs contributes to HCC initiation in the context of MASH, potentially involving its described non-canonical role within mitochondria, promoting oxidative stress, a cancer hallmark. This study provides new insights into evaluating the therapeutic potential of targeting MLKL, as its inhibition in LPCs may represent an effective strategy for treating MASH-related HCC.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08458-x","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:47:11Z","timestamp":1771462031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MLKL in liver parenchymal cells promotes liver cancer in murine metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6814-8978","authenticated-orcid":false,"given":"Ghiles","family":"Imerzoukene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-7551","authenticated-orcid":false,"given":"Ghania Hounana","family":"Kara-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Heitz-Marchaland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Simoes Eug\u00e9nio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna\u00efg","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Bidon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gevorg","family":"Ghukasyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Dubreil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3783-0879","authenticated-orcid":false,"given":"Nicolas","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8428-9558","authenticated-orcid":false,"given":"C\u00e9line","family":"Raguenes-Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Piquet-Pellorce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Th\u00e9r\u00e8se","family":"Dimanche-Boitrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-3311","authenticated-orcid":false,"given":"Jacques","family":"Le Seyec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"8458_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers"},{"key":"8458_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16:411\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8458_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/jpm14040370","volume":"14","author":"C Leyh","year":"2024","unstructured":"Leyh C, Coombes JD, Schmidt HH, Canbay A, Manka PP, Best J. MASLD-related HCC\u2014update on pathogenesis and current treatment options. J Pers Med. 2024;14:370.","journal-title":"J Pers Med"},{"key":"8458_CR4","first-page":"00418","volume":"S0168-8278","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;S0168-8278:00418\u2013X.","journal-title":"J Hepatol"},{"key":"8458_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22:429\u201343.","journal-title":"Nat Rev Immunol"},{"key":"8458_CR6","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324.","journal-title":"Lancet"},{"key":"8458_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","volume":"20","author":"JM Llovet","year":"2023","unstructured":"Llovet JM, Willoughby CE, Singal AG, Greten TF, Heikenw\u00e4lder M, El-Serag HB, et al. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol. 2023;20:487\u2013503.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8458_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322.","journal-title":"Nat Med"},{"key":"8458_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/CS20140732","volume":"129","author":"MB Afonso","year":"2015","unstructured":"Afonso MB, Rodrigues PM, Carvalho T, Caridade M, Borralho P, Cortez-Pinto H, et al. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin Sci (Lond). 2015;129:721\u201339.","journal-title":"Clin Sci (Lond)"},{"key":"8458_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jcmgh.2015.02.001","volume":"1","author":"J Gautheron","year":"2015","unstructured":"Gautheron J, Vucur M, Luedde T. Necroptosis in nonalcoholic steatohepatitis. Cell Mol Gastroenterol Hepatol. 2015;1:264\u20135.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"8458_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang H, Sun L, Su L, Rizo J, Liu L, Wang L-F, et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014;54:133\u201346.","journal-title":"Mol Cell"},{"key":"8458_CR12","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.7150\/thno.54072","volume":"11","author":"C Zhan","year":"2021","unstructured":"Zhan C, Huang M, Yang X, Hou J. MLKL: Functions beyond serving as the executioner of necroptosis. Theranostics. 2021;11:4759\u201369.","journal-title":"Theranostics"},{"key":"8458_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molmet.2019.02.003","volume":"23","author":"H Xu","year":"2019","unstructured":"Xu H, Du X, Liu G, Huang S, Du W, Zou S, et al. The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation. Mol Metab. 2019;23:14\u201323.","journal-title":"Mol Metab"},{"key":"8458_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2020.03.023","volume":"73","author":"X Wu","year":"2020","unstructured":"Wu X, Poulsen KL, Sanz-Garcia C, Huang E, McMullen MR, Roychowdhury S, et al. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis. J Hepatol. 2020;73:616\u201327.","journal-title":"J Hepatol"},{"key":"8458_CR15","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/jgh.14740","volume":"34","author":"WK Saeed","year":"2019","unstructured":"Saeed WK, Jun DW, Jang K, Oh JH, Chae YJ, Lee JS, et al. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase. J Gastroenterol Hepatol. 2019;34:2206\u201318.","journal-title":"J Gastroenterol Hepatol"},{"key":"8458_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/1533034616655909","volume":"16","author":"X Li","year":"2017","unstructured":"Li X, Guo J, Ding A-P, Qi W-W, Zhang P-H, Lv J, et al. Association of mixed lineage kinase domain-like protein expression with prognosis in patients with colon cancer. Technol Cancer Res Treat. 2017;16:428\u201334.","journal-title":"Technol Cancer Res Treat"},{"key":"8458_CR17","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1007\/s13277-016-5229-1","volume":"37","author":"Z Ertao","year":"2016","unstructured":"Ertao Z, Jianhui C, Kang W, Zhijun Y, Hui W, Chuangqi C, et al. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric cancer. Tumour Biol. 2016;37:13679\u201385.","journal-title":"Tumour Biol"},{"key":"8458_CR18","first-page":"1539","volume":"6","author":"L He","year":"2013","unstructured":"He L, Peng K, Liu Y, Xiong J, Zhu F-F. Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients. Onco Targets Ther. 2013;6:1539\u201343.","journal-title":"Onco Targets Ther"},{"key":"8458_CR19","doi-asserted-by":"publisher","first-page":"e0228015","DOI":"10.1371\/journal.pone.0228015","volume":"15","author":"Y Ando","year":"2020","unstructured":"Ando Y, Ohuchida K, Otsubo Y, Kibe S, Takesue S, Abe T, et al. Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5. PLoS One. 2020;15:e0228015.","journal-title":"PLoS One"},{"key":"8458_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41421-022-00504-0","volume":"9","author":"X Jiang","year":"2023","unstructured":"Jiang X, Deng W, Tao S, Tang Z, Chen Y, Tian M, et al. A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma. Cell Discov. 2023;9:7.","journal-title":"Cell Discov"},{"key":"8458_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","volume":"39","author":"JM Murphy","year":"2013","unstructured":"Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang J-G, Alvarez-Diaz S, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity. 2013;39:443\u201353.","journal-title":"Immunity"},{"key":"8458_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E","volume":"26","author":"C Kellendonk","year":"2000","unstructured":"Kellendonk C, Opherk C, Anlag K, Sch\u00fctz G, Tronche F. Hepatocyte-specific expression of Cre recombinase. Genesis. 2000;26:151\u20133.","journal-title":"Genesis"},{"key":"8458_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jhep.2020.05.016","volume":"73","author":"A Hamon","year":"2020","unstructured":"Hamon A, Piquet-Pellorce C, Dimanche-Boitrel M-T, Samson M, Le Seyec J. Intrahepatocytic necroptosis is dispensable for hepatocyte death in murine immune-mediated hepatitis. J Hepatol. 2020;73:699\u2013701.","journal-title":"J Hepatol"},{"key":"8458_CR24","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/cancers12061491","volume":"12","author":"M Simoes Eug\u00e9nio","year":"2020","unstructured":"Simoes Eug\u00e9nio M, Farooq M, Dion S, Devisme C, Raguenes-Nicol C, Piquet-Pellorce C, et al. Hepatocellular carcinoma emergence in diabetic mice with non-alcoholic steatohepatitis depends on diet and is delayed in liver exhibiting an active immune response. Cancers (Basel). 2020;12:1491.","journal-title":"Cancers (Basel)"},{"key":"8458_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.70013","volume":"3","author":"M Richard","year":"2024","unstructured":"Richard M, Moreau R, Croyal M, Mathiot L, Fr\u00e9nel J-S, Campone M, et al. Monitoring concentration and lipid signature of plasma extracellular vesicles from HR+ metastatic breast cancer patients under CDK4\/6 inhibitors treatment. J Extracell Biol. 2024;3:e70013.","journal-title":"J Extracell Biol"},{"key":"8458_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.febslet.2004.10.067","volume":"578","author":"A Galinier","year":"2004","unstructured":"Galinier A, Carri\u00e8re A, Fernandez Y, Bessac AM, Caspar-Bauguil S, Periquet B, et al. Biological validation of coenzyme Q redox state by HPLC-EC measurement: relationship between coenzyme Q redox state and coenzyme Q content in rat tissues. FEBS Lett. 2004;578:53\u201357.","journal-title":"FEBS Lett"},{"key":"8458_CR27","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/ijc.34869","volume":"154","author":"GH Kara-Ali","year":"2024","unstructured":"Kara-Ali GH, Cano L, Dion S, Imerzoukene G, Hamon A, Simoes Eug\u00e9nio M, et al. Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation. Int J Cancer. 2024;154:1999\u20132013.","journal-title":"Int J Cancer"},{"key":"8458_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1400961","volume":"15","author":"B Ramos-Molina","year":"2024","unstructured":"Ramos-Molina B, Rossell J, P\u00e9rez-Montes de Oca A, Pardina E, Genua I, Rojo-L\u00f3pez MI, et al. Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis. Front Endocrinol (Lausanne). 2024;15:1400961.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8458_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1872-034X.2010.00643.x","volume":"40","author":"K Suzuki","year":"2010","unstructured":"Suzuki K, Kirikoshi H, Yoneda M, Mawatari H, Fujita K, Nozaki Y, et al. Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis. Hepatol Res. 2010;40:693\u2013700.","journal-title":"Hepatol Res"},{"key":"8458_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1023\/A:1005446418589","volume":"45","author":"Y Tsushima","year":"2000","unstructured":"Tsushima Y, Endo K. Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci. 2000;45:196\u2013200.","journal-title":"Dig Dis Sci"},{"key":"8458_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101220","volume":"6","author":"BQ Yang","year":"2024","unstructured":"Yang BQ, Chan MM, Heo GS, Lou L, Luehmann H, Park C, et al. Molecular imaging of macrophage composition and dynamics in MASLD. JHEP Rep. 2024;6:101220.","journal-title":"JHEP Rep"},{"key":"8458_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12072-018-9860-3","volume":"12","author":"T Takahashi","year":"2018","unstructured":"Takahashi T, Deuschle U, Taira S, Nishida T, Fujimoto M, Hijikata T, et al. Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation. Hepatol Int. 2018;12:254\u201361.","journal-title":"Hepatol Int"},{"key":"8458_CR33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1136\/gutjnl-2011-301862","volume":"61","author":"S Tremosini","year":"2012","unstructured":"Tremosini S, Forner A, Boix L, Vilana R, Bianchi L, Reig M, et al. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut. 2012;61:1481\u20137.","journal-title":"Gut"},{"key":"8458_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12598","volume":"7","author":"Z-Z Chen","year":"2016","unstructured":"Chen Z-Z, Huang L, Wu Y-H, Zhai W-J, Zhu P-P, Gao Y-F. LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression. Nat Commun. 2016;7:12598.","journal-title":"Nat Commun"},{"key":"8458_CR35","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41586-025-09072-1","volume":"643","author":"RLS Goncalves","year":"2025","unstructured":"Goncalves RLS, Wang ZB, Riveros JK, Parlakg\u00fcl G, Inouye KE, Lee GY, et al. CoQ imbalance drives reverse electron transport to disrupt liver metabolism. Nature. 2025;643:1057\u201365.","journal-title":"Nature"},{"key":"8458_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3164\/jcbn.19-105","volume":"68","author":"Y-S Li","year":"2021","unstructured":"Li Y-S, Kawasaki Y, Watanabe S, Ootsuyama Y, Kasai H, Kawai K. Diurnal and day-to-day variation of urinary oxidative stress marker 8-hydroxy-2\u2019-deoxyguanosine. J Clin Biochem Nutr. 2021;68:18\u201322.","journal-title":"J Clin Biochem Nutr"},{"key":"8458_CR37","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3390\/ijms18081801","volume":"18","author":"A Kakehashi","year":"2017","unstructured":"Kakehashi A, Ishii N, Okuno T, Fujioka M, Gi M, Wanibuchi H. Enhanced susceptibility of Ogg1 mutant mice to multiorgan carcinogenesis. Int J Mol Sci. 2017;18:1801.","journal-title":"Int J Mol Sci"},{"key":"8458_CR38","first-page":"5378","volume":"61","author":"NC De Souza-Pinto","year":"2001","unstructured":"De Souza-Pinto NC, Eide L, Hogue BA, Thybo T, Stevnsner T, Seeberg E, et al. Repair of 8-oxodeoxyguanosine lesions in mitochondrial dna depends on the oxoguanine dna glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial dna of OGG1-defective mice. Cancer Res. 2001;61:5378\u201381.","journal-title":"Cancer Res"},{"key":"8458_CR39","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1053\/j.gastro.2022.08.040","volume":"163","author":"SP Preston","year":"2022","unstructured":"Preston SP, Stutz MD, Allison CC, Nachbur U, Gouil Q, Tran BM, et al. Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies. Gastroenterology. 2022;163:1643\u20131657.e14.","journal-title":"Gastroenterology"},{"key":"8458_CR40","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.7150\/thno.71400","volume":"12","author":"R Guo","year":"2022","unstructured":"Guo R, Jia X, Ding Z, Wang G, Jiang M, Li B, et al. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation. Theranostics. 2022;12:5220\u201336.","journal-title":"Theranostics"},{"key":"8458_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp8309","volume":"14","author":"H Shi","year":"2022","unstructured":"Shi H, Wang X, Li F, Gerlach BD, Yurdagul A, Moore MP, et al. CD47-SIRP\u03b1 axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis. Sci Transl Med. 2022;14:eabp8309.","journal-title":"Sci Transl Med"},{"key":"8458_CR42","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1136\/gutjnl-2020-321767","volume":"70","author":"MB Afonso","year":"2021","unstructured":"Afonso MB, Rodrigues PM, Mateus-Pinheiro M, Sim\u00e3o AL, Gaspar MM, Majdi A, et al. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease. Gut. 2021;70:2359\u201372.","journal-title":"Gut"},{"key":"8458_CR43","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.immuni.2023.05.017","volume":"56","author":"M Vucur","year":"2023","unstructured":"Vucur M, Ghallab A, Schneider AT, Adili A, Cheng M, Castoldi M, et al. Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity. 2023;56:1578\u20131595.e8.","journal-title":"Immunity"},{"key":"8458_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.907036","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Wang S, Blokhuis B, Ruijtenbeek R, Garssen J, Redegeld F. Cell Death Triggers induce MLKL cleavage in multiple myeloma cells, which may promote cell death. Front Oncol. 2022;12:907036.","journal-title":"Front Oncol"},{"key":"8458_CR45","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/hep.32612","volume":"77","author":"X Wu","year":"2023","unstructured":"Wu X, Fan X, McMullen MR, Miyata T, Kim A, Pathak V, et al. Macrophage-derived MLKL in alcohol-associated liver disease: regulation of phagocytosis. Hepatology. 2023;77:902\u201319.","journal-title":"Hepatology"},{"key":"8458_CR46","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/1541-7786.MCR-22-0820","volume":"21","author":"S Mohammed","year":"2023","unstructured":"Mohammed S, Thadathil N, Ohene-Marfo P, Tran AL, Van Der Veldt M, Georgescu C, et al. Absence of either Ripk3 or Mlkl reduces incidence of hepatocellular carcinoma independent of liver fibrosis. Mol Cancer Res. 2023;21:933\u201346.","journal-title":"Mol Cancer Res"},{"key":"8458_CR47","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","volume":"4","author":"S Gallage","year":"2022","unstructured":"Gallage S, Avila JEB, Ramadori P, Focaccia E, Rahbari M, Ali A, et al. A researcher\u2019s guide to preclinical mouse NASH models. Nat Metab. 2022;4:1632\u201349.","journal-title":"Nat Metab"},{"key":"8458_CR48","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3389\/fimmu.2019.02893","volume":"10","author":"JR Oates","year":"2019","unstructured":"Oates JR, McKell MC, Moreno-Fernandez ME, Damen MSMA, Deepe GS, Qualls JE, et al. Macrophage function in the pathogenesis of non-alcoholic fatty liver disease: the Mac attack. Front Immunol. 2019;10:2893.","journal-title":"Front Immunol"},{"key":"8458_CR49","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2147\/JHC.S377768","volume":"9","author":"S Yu","year":"2022","unstructured":"Yu S, Wang J, Zheng H, Wang R, Johnson N, Li T, et al. Pathogenesis from inflammation to cancer in NASH-derived HCC. J Hepatocell Carcinoma. 2022;9:855\u201367.","journal-title":"J Hepatocell Carcinoma"},{"key":"8458_CR50","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s12276-020-0480-3","volume":"52","author":"S-Y Koo","year":"2020","unstructured":"Koo S-Y, Park E-J, Lee C-W. Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma. Exp Mol Med. 2020;52:1209\u201319.","journal-title":"Exp Mol Med"},{"key":"8458_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.760860","volume":"12","author":"P Hirsova","year":"2021","unstructured":"Hirsova P, Bamidele AO, Wang H, Povero D, Revelo XS. Emerging roles of T cells in the pathogenesis of nonalcoholic steatohepatitis and hepatocellular carcinoma. Front Endocrinol (Lausanne). 2021;12:760860.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8458_CR52","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1089\/ars.2022.0047","volume":"37","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang X, Kuang M, Yu J. Emerging Insights on Immunotherapy in Liver Cancer. Antioxidants & Redox Signaling. 2022;37:1325\u201338.","journal-title":"Antioxidants & Redox Signaling"},{"key":"8458_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-023-01356-7","volume":"9","author":"H Zheng","year":"2023","unstructured":"Zheng H, Peng X, Yang S, Li X, Huang M, Wei S, et al. Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy. Cell Death Discov. 2023;9:1\u201315.","journal-title":"Cell Death Discov"},{"key":"8458_CR54","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF03401737","volume":"4","author":"RS Kerbel","year":"1998","unstructured":"Kerbel RS, Viloria-Petit A, Okada F, Rak J. Establishing a link between oncogenes and tumor angiogenesis. Mol Med. 1998;4:286\u201395.","journal-title":"Mol Med"},{"key":"8458_CR55","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cmet.2025.01.016","volume":"37","author":"J Jiang","year":"2025","unstructured":"Jiang J, Gao Y, Wang J, Huang Y, Yang R, Zhang Y, et al. Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism. Cell Metab. 2025;37:1119\u20131136.e13.","journal-title":"Cell Metab"},{"key":"8458_CR56","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/gutjnl-2020-323323","volume":"71","author":"S Smati","year":"2022","unstructured":"Smati S, Polizzi A, Fougerat A, Ellero-Simatos S, Blum Y, Lippi Y, et al. Integrative study of diet-induced mouse models of NAFLD identifies PPAR\u03b1 as a sexually dimorphic drug target. Gut. 2022;71:807\u201321.","journal-title":"Gut"},{"key":"8458_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13248","volume":"22","author":"S Sindhu","year":"2021","unstructured":"Sindhu S, Leung YH, Arefanian H, Madiraju SRM, Al-Mulla F, Ahmad R, et al. Neutral sphingomyelinase-2 and cardiometabolic diseases. Obes Rev. 2021;22:e13248.","journal-title":"Obes Rev"},{"key":"8458_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1512968","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wei W, Zhang Y, Miao J, Bao X, Lu C. MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics. Front Pharmacol. 2025;16:1512968.","journal-title":"Front Pharmacol"},{"key":"8458_CR59","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000425","volume":"8","author":"J Lyu","year":"2024","unstructured":"Lyu J, Okada H, Sunagozaka H, Kawaguchi K, Shimakami T, Nio K, et al. Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis. Hepatol Commun. 2024;8:e0425.","journal-title":"Hepatol Commun"},{"key":"8458_CR60","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/antiox13111415","volume":"13","author":"K Kaji","year":"2024","unstructured":"Kaji K, Takeda S, Iwai S, Nishimura N, Sato S, Namisaki T, et al. Imeglimin halts liver damage by improving mitochondrial dysfunction in a nondiabetic male mouse model of metabolic dysfunction-associated Steatohepatitis. Antioxidants (Basel). 2024;13:1415.","journal-title":"Antioxidants (Basel)"},{"key":"8458_CR61","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168476","volume":"9","author":"P Fern\u00e1ndez-Tussy","year":"2024","unstructured":"Fern\u00e1ndez-Tussy P, Cardelo MP, Zhang H, Sun J, Price NL, Boutagy NE, et al. miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression. JCI Insight. 2024;9:e168476.","journal-title":"JCI Insight"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08458-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:03:00Z","timestamp":1771520580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08458-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8458"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08458-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}